source
- Biotech startups opt out of AI for drug discovery, say STATThe latest STAT AI Prognosis newsletter notes that a number of biotech startups are deliberately avoiding artificial intelligence in their drug discovery programs. These companies argue that AI ma…
- MiniMed appoints diabetes and digital health veteran David Segal as chief medical officerMiniMed, the insulin pump maker that spun off from Medtronic, announced the appointment of Dr. David Segal as its new chief medical officer. Segal replaces Dr. Robert Vigersky, who has served as C…